The University of Chicago Header Logo

Connection

Marina Chiara Garassino to Ligands

Back to Details
This is a "connection" page, showing publications Marina Chiara Garassino has written about Ligands.
Marina Chiara Garassino
Connection Strength
0.047
Ligands
  1. Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study. J Thorac Oncol. 2023 02; 18(2):181-193.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.